Gastric Acid Regulation Drugs
On this page
Direct answer
Every acid-suppressing drug converges on the parietal cell, where three receptors — M3 (acetylcholine), CCK2 (gastrin) and H2 (histamine, via cAMP) — feed one final common pathway, the H+/K+ ATPase proton pump. Proton pump inhibitors (omeprazole, pantoprazole, rabeprazole, esomeprazole) covalently kill that pump; H2 blockers (famotidine) mute only the histamine arm; antacids neutralise acid after it forms; sucralfate and bismuth armour the mucosa; misoprostol restores prostaglandin defence. PPIs are prodrugs that activate only in the acidic canaliculus of pumps a meal has recruited — hence dosing 30–60 minutes before breakfast, a timing rule examiners ask more often than the mechanism.
What you must remember
- PPI pharmacology: inactive weak bases activated at canaliculus pH below about 2; covalent, irreversible H+/K+ ATPase inhibition; plasma half-life around an hour but acid suppression lasts 24+ hours because pumps must be resynthesised.
- Timing: take 30–60 minutes before breakfast — the meal both wakes the pumps (for activation) and would otherwise acid-suppress poorly; twice-daily PPI means a second pre-meal dose, not bedtime.
- H2 blockers: famotidine 20–40 mg — fast, cheap; tachyphylaxis develops within days, capping sustained use; cimetidine inhibits CYP1A2/2C9/3A4 (warfarin, phenytoin, theophylline) and has antiandrogenic effects (gynaecomastia, impotence).
- Ranitidine: suspended by CDSCO in India in 2020 over NDMA impurity concerns and dropped from NLEM 2022 — the pharmacovigilance case study in this class.
- Antacids: aluminium hydroxide (constipation, phosphate binding) balanced with magnesium salts (osmotic diarrhoea); calcium carbonate causes acid rebound; ideal for on-demand dyspepsia.
- Sucralfate: polymerises only in acid — dose before meals, never co-administer with PPI or antacid; binds ulcer base, useful in pregnancy and bleeding-risk contexts.
- Misoprostol 200 μg QID: PGE1 analogue for NSAID-ulcer prophylaxis; diarrhoea and dose-related uterine contraction — absolutely contraindicated in pregnancy.
- Bismuth: black tongue and stools (warn patients); a component of H. pylori bismuth quadruple therapy.
- PPI long-term associations: C. difficile and community pneumonia risk, hypomagnesaemia, B12 malabsorption, fracture risk, fundic gland polyps; omeprazole interacts with clopidogrel via CYP2C19 (pantoprazole is the low-interaction choice).
Mapping drugs onto the parietal cell
Draw the cell and the class writes itself. Histamine from enterochromaffin-like cells hits H2 receptors — famotidine's post. Gastrin and vagal acetylcholine arrive at CCK2 and M3 — no licensed drug blocks either in the stomach, which is exactly why H2 blockade alone fails: the other two arms still drive cAMP-calcium signalling, and tolerance compounds the leak. Everything funnels into the H+/K+ ATPase on the apical membrane — the PPI's target, and the reason PPI inhibition is total regardless of which stimulant initiated secretion. Above the membrane sit the defenders: sucralfate polymerising into an acid-resistant crust over the ulcer, bismuth adding its own antimicrobial and mucosal coat, misoprostol restoring the prostaglandin-mediated mucus-bicarbonate buffer that NSAIDs strip away. The canaliculus's pH 1 environment is both the PPI's activation chamber and the reason the prodrug must be enteric-coated — swallowed omeprazole granules survive the gastric lumen intact and dissolve only in the alkaline duodenum. One diagram, every drug placed, nothing left to memorise as a list.
Where students slip
The most common slip is timing: a PPI swallowed after breakfast suppresses far less because the pumps it needed to activate were already past recruitment — the "before meals" instruction is pharmacology, not convenience. Second, H2RA tachyphylaxis: famotidine works brilliantly on day one and less each week, so quoting it as chronic GERD therapy loses marks. Third, sucralfate given with a PPI or antacid fails to polymerise — the interaction is the exam point. Fourth, the cimetidine interaction set is fading from fashion while the ranitidine NDMA withdrawal is the current pharmacovigilance star; know both. Finally, misoprostol's dual identity — ulcer prophylaxis and abortifacient — makes "contraindicated in pregnancy" the one sentence that must appear in every answer mentioning it.
Frequently asked questions
Why must PPIs be taken before meals?
They are prodrugs activated only in acid-secreting pumps; a meal recruits pumps, so dosing 30–60 minutes beforehand maximises activation and suppression.
Why do H2 blockers lose effect over days?
Functional tachyphylaxis develops at the H2 receptor within about a week, blunting sustained acid suppression.
Why is sucralfate not given with PPIs or antacids?
Sucralfate needs an acidic environment to polymerise into its protective gel; acid suppression prevents that reaction.
What happened to ranitidine in India?
CDSCO suspended it in 2020 over NDMA impurity concerns, and it was removed from NLEM 2022 — famotidine remains the practical H2 blocker.
What is the classic PPI–clopidogrel issue?
Omeprazole inhibits CYP2C19, reducing clopidogrel's activation; pantoprazole has minimal interaction and is preferred.